The relative concentrations, expressed as the ratio of 24,25-(0H)zD to 25-OHD, were comparable to those of the adults at birth, but decreased significantly within 2 wk. The data demonstrate that healthy premature infants can produce high plasma levels of 1,25-(oH)~D.
The main function of vitamin D is to enhance intestinal absorption of calcium (Ca) and phophorus (P) (reviews 12, 15) . This effect, however, is first achieved after a series of metabolic alterations. The vitamin is first hydroxylated to 25-OHD in the liver, and then to 1 ,25-(OH)2D, which is the principal metabolite with biologic activity, in the kidneys. The circulating concentration of 1,25-(OH)2D is regulated according to the body's need for Ca and P (12, 15) . Other vitamin D metabolites have also been isolated. 24,25-(OH)2D has received most attention, but its significance remains to be clarified (1 2, 15).
Rickets is not uncommon in premature infants (7, 23, 31) . Several factors are probably of pathogenetic importance (5, 7, 10, 25, 30) , and deficient functions in all aspects of vitamin D metabolism have been implicated, such as: intestinal absorption (21, 31, 37), hepatic 25-hydroxylation (19, 21, 31) , renal 1-hydroxylation (2 1, 3 l), and intestinal responsiveness to 1,25- Table 1 . Daily intakes of vitamin D, Ca, and P when oral (0H)zD (8) .
feedings were we1 established The purpose of this investigation was to study the ability of (14) , was 33 (range 28-36) wk, and median birth weight was 1880 (range 900-2350) g. Three infants were small for gestational age (birth weight below the 2.5 percentile), the remaining had appropriate weights. Eight ' were products of five twin pregnancies. All had an un~ventful neonatal course and were on full oral feeds within 7 d of birth. Eight infants temporarily received Ca supplements orally or intravenously because of asymptomatic early hypocalcemia, but this was discontinued before the age of 1 wk. All received breast milk, but various volumes of a commercial formula were added if breast milk supply was inadequate. The formula was based on cow's milk and contained 67 kcal, 600 mg Ca, 450 mg P, and 450 IU vitamin D3 per liter. Mother's milk was estimated to contain 280 mg Ca and 140 mg P (4), pooled breast milk 270 mg Ca and 130 mg P (4, 18) , and both 25 IU vitamin D3 per liter (22) . All received an additional daily supplement of 500 IU vitamin D2 given as an aqueous suspension. This was started on d 4 in 20 of the infants, but for reasons unrelated to clinical condition delayed until d 6-14 in the remaining infants. Mineral and vitamin D intakes were calculated on the basis of accurate records regarding volume and type of milk ingested.
Heparinized venous blood was collected at the following ages:
3-4 wk (n = 14), and 5-10 wk (n = 16). Seventeen patients had two or more samples drawn. A minimum of trauma from venipuncture was accepted, however, making a serial study unfeasible. The plasma was immediately separated and stored at -20°C until analysis.
Seventeen adults (age 24-36 yr) served as a reference group. In Norway the margarine is fortified with vitamin D3 and supplies an average of around 100 IU/d to adults. No supplements were otherwise given, but they were studied during the summer and consequently exposed to sunshine.
The vitamin D metabolites 25-OHD, 1,25-(0H)zD and 24,25-(OH),D were extracted from 0.5-0.6 ml of plasma with diethylether, and purified and separated on open silicic acid columns and by high pressure liquid chromatography according to methods previously described from our laboratory (I). 1,25-(OH)2D was determined quantitatively by a competitive protein binding assay using duodenal cytosol from rachitic chicks as binding protein (2) . 25-OHD and 24,25-(OH),D concentrations were assessed similarly by using human serum as binding protein (2) . After the specific extraction and purification methods used, we have not found detectable levels of calcidiol lactone in human plasma, a metabolite claimed to interfere with the determination of 24,25-(OH)2D (13) . Care was taken to include both vitamin D2 and D, metabolites in the assays. The intra-and inter-assay coefficients of variation have been found to be 6.3 and 8.5%, respectively for 25-OHD, 9.7 and 12.1 % for 1,25-(OH)2D, and 7.0 and 9.7% for 24,25-(OH)2D. Plasma Ca was measured by atomic absorption, and P and alkaline phosphatase by standard laboratory methods (6, 17) .
Biochemical data were expressed as medians with the range and analyzed statistically using the Wilcoxon's two sample test unless otherwise specified in the text. Correlations were calculated using linear regression analysis.
RESULTS
The Vitamin D, Ca, and P intakes on well established oral feedings are listed in The median plasma concentration of Ca was 7.7 mg/dl (7.1-9.9) on d 1, 9.0 mg/dl (7.1-12.0) on d 3, and 10.0 mg/dl (9.5-11.0) on d 7 after birth ( P < 0.05 for all differences). Ca and P levels did not change beyond 1 wk of age, and were within normal limits for children (32) . Data on alkaline phosphatase concentrations were incomplete in that only 6 infants were studied at the age of 1-2 wk, 9 at 3-4 wk, and 12 at 5-10 wk. All values were within the normal range of 275-1050 U/liter for term infants less than 2 mo of age (24) , and the median level did not change significantly with time.
For all age groups plasma 1 ,25-(OH)2D concentrations showed wide variations (Fig. 1) . On d I of life the values were in the normal adult range (median 37 versus 35 pg/ml), but there was a significant increase from 1 d to 1 wk, and further from I until 3-4 wk of age (Fig. I) . The levels of 3-4 and 5-10 wk did not differ significantly, and the median value was more than 3 times higher than that of the adults (Fig. 1) .
Twelve of the patients were studied at both 1 and 3 d of age. When these results were tested separately as paired samples, a significant rise in 1,25-(OH)2D was apparent even within this time span (median 4 1, range 8-64 versus 48, range 23-104, P = 0.02, Wilcoxon's paired sample test). The median gestational age and birth weight for these infants were similar to those of the total group (33.5, range 30-35 wk and 1720, range 1210-2350 g).
The plasma levels of vitamin D metabolites in the eight patients with early neonatal hypocalcemia did not differ significantly from the rest of the infants. Furthermore, there were no significant correlations between 1 ,25-(OH)2D and birth weight, gestational age, plasma Ca, or 25-OHD at any age. At 5-10 wk there was, however, a negative correlation between 1,25-(0H)zD levels and plasma P ( r = -0.59, P < 0.025), P intake (r = -0.48, P < 0.05), and Ca intake (r = 0.52, P < 0.05).
The concentrations of 24,25-(OH),D were low compared with the adult values ( P < 0.0 1, Table 2 ), and did not change significantly during the study period. The 25-OHD levels increased, however, and when the 24,25-(0H)zD concentrations were expressed in relative terms as the ratio to 25-OHD, the values were similar to those found in adults in the immediate postnatal period, but decreased significantly within 2 wk ( P < 0.01, Table   2 ). There were no significant correlations between 24,25-(OH)2D or the ratio of 24,25-(OH)2D to 250HD, and Ca, P or alkaline phosphatase levels, or Ca and P intakes. OHD level. The initial median level was, however, below the low normal limit of 12 ng/ml established for children and adults in our laboratory. In contrast to Glorieux et al. (16) we found no correlation between 25-OHD and 1 ,25-(OH)2D concentrations to suggest that the low initial 25-OHD levels inhibited the early synthesis of 1,25-(OH)2D. This discrepancy may be due possibly to a higher average 25-OHD level in our infants (median 11 versus mean 8 ng/ml), and a pharmacologic effect of high vitamin D intake in the referred group (16). An increased incidence of neonatal hypocalcemia has been reported in infants of vitamin-D-deficient mothers (1 1, 27). The concomitant increases in 1,25-(OH)2D and plasma Ca during the first week of life in our infants lends further support to the notion that vitamin D metabolism is of importance in the perinatal adjustment of mineral homeostasis. The lack of significant correlation between simultaneous 1,25-(0H)zD and Ca levels suggests, however, that other factors such as parathyroid function or Ca intake are also important (20, 29) .
The Ca and P intakes of our infants varied according to the relative volumes of breast milk and formula ingested. All received, however, considerably less than the expected intrauterine accretion rates of approximately 150 mg Ca and 95 mg P per kg body weight per day (38) . Furthermore, Steichen et al. (34) found that a mineral supply similar to our regime was inadequate to prevent osteopenia in small premature infants. The high 1,25-(OH)2D concentrations beyond the perinatal period may therefore represent a normal compensatory effect to ensure maximum Ca and P absorption from a relatively mineral deficient diet (12, 15) . The negative correlations between 1,25-(OH)2D and plasma P and mineral intake in the 5-10-wk-old infants support this assumption.
In humans, no physiologic effects of 24,25-(0H)zD have yet been established (12) . Details regarding the regulation of its synthesis are also uncertain, but the plasma concentration has been found to correlate positively with the 25-OHD level (3, 33, 36) . The relative concentration of 24,25-(OH),D, expressed as the ratio of 24,25-(0H)zD to 25-OHD, therefore gives a measure of the degree to which 25-OHD is transformed to 24,25-(OH)2D. In older individuals this ratio falls reciprocally to the 1,25-(OH)2D concentration indicating a preference for hydroxylation in the carbon 1 position during periods of high demands for Ca and P, such as rapid linear growth (3) and pregnancy (26). \
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Although we cannot exclude that the low levels of 24,25-(OH)*D in our infants were due to enzyme deficiency because of prematurity, the high levels of 1,25-(OH),D together with the low 24,25-(OH),D concentration and the low ratio of 24,25-(OH),D to 25-OHD in rapidly growing premature infants are in agreement with such a model, and indicate that the vitamin D metabolism is adjusted to meet these infants' needs for maximum Ca and P retention.
